Business of Cannabis North America
US recommendation to reschedule cannabis marks ‘significant shift in drug policy’ and ‘new opportunities’ for industry
The US Department of Health and Human Services (HHS) recommendation to reschedule cannabis marks a significant shift in drug policy,